Back to Journals » Cancer Management and Research » Volume 11

Original Research

Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer

       
Total article views   HTML views PDF downloads Totals
6,136 Dovepress* 5,602+ 778 6,380
PubMed Central* 534 206 740
Totals 6,136 984 7,120
*Since 12 December 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar